CD19 + CAR T-cells used for the treatment of relapsed/refractory ALL may cause hyponatremia due to hypercytokinemia and elevated IL-6, which stimulates the hypothalamus for the inappropriate release of ADH [150]. Here, IL6 is linked to Hyponatremia.